论文部分内容阅读
肿瘤的耐药检查是近几年来国内外开展的项目。以往文献报告仅将耐药检测作为肿瘤标记物,而真正应用于临床,指导化疗则文献报告甚少。随着肿瘤耐药研究的不断深入及化疗药物的广泛应用,我们开展了P170、GST π在人体肿瘤中的检测,试图从肿瘤的耐药方面为临床提供依据,用于指导临床化疗。 材料和方法 本组材料来自我院1995年6月至10月切除的乳腺癌标本。在常规染色的同时用免疫组化ABC及
The drug resistance check of tumors is a project carried out at home and abroad in recent years. The previous literature reports only used drug resistance testing as a tumor marker, but it was actually applied to clinics and there were few reports on the use of chemotherapy. With the deepening of tumor drug resistance research and the widespread application of chemotherapeutic drugs, we have carried out the detection of P170 and GST π in human tumors, trying to provide evidence for the clinical aspects of tumor resistance and guiding clinical chemotherapy. Materials and Methods The materials in this group were from breast cancer specimens removed from June to October 1995 in our hospital. Using immunohistochemical ABC and conventional staining